GlobeNewswire by notified

Acron Group’s Commercial Output Up 6% in 9M 2021


15 October 2021

Acron Group’s Commercial Output Up 6% in 9M 2021

Group’s Consolidated Output (including operating results for Acron, Dorogobuzh and North-Western Phosphorous Company)

Product, ‘000 t9M 20219M 2020YOY, %
Incl. in-house consumption2,1131,980
Nitrogen fertilisers, including3,7503,6343.2
Incl. in-house consumption689562
Incl. in-house consumption232170
Incl. in-house consumption456391
        Including prilled urea273381-28.5
        Incl. in-house consumption1511
        Including granulated urea364145150.5
        Incl. in-house consumption2719
Complex fertilisers, including1,9451,74711.4
Incl. in-house consumption4027
Incl. in-house consumption4027
Bulk blends1478475.4
Total commercial output for Mineral Fertilisers5,0174,8842.7
Organic compounds, including36730719.3
Incl. in-house consumption191155
Incl. in-house consumption7157
Incl. in-house consumption11796
Urea-formaldehyde resins15412722.0
Incl. in-house consumption42
Non-organic compounds, including:89075717.5
Low-density and technical-grade AN36824649.3
Industrial urea1209231.4
Calcium carbonate353373-5.4
Liquid carbon dioxide44417.6
Total commercial output

for Industrial Products
Apatite concentrate93684810.3
Incl. in-house consumption704684
Total commercial output

for Apatite Concentrate

Note: Commercial output is output less in-house consumption.

Comments from Alexander Popov, Chairman of Acron’s Board of Directors:

‘In 9M 2021, Acron Group set a new output record. In the reporting period, the Group produced 6,315,000 tonnes of commercial products, up 6% year-on-year. Mineral fertiliser output was up 3% to 5,017,000 tonnes.

‘The strong demand we are seeing as the global economy recovers from the COVID-19 crisis requires that we be as focused and efficient as possible. While some producers are experiencing difficulties with logistics and feedstock supply, Acron Group sees providing farmers with fertilisers as the key objective for the entire system of food production.

‘In this context, the Urea-6+ project, which significantly boosted our output of this world’s most popular fertiliser, appears to be perfectly aligned with the market’s needs. Since August, the unit has been operating at increased capacity, and the results are visible, with output of agricultural urea up 18% year-on-year. It is important for us that the project is in line with Acron’s ESG principles: the upgraded operations include a cutting-edge unit for wastewater fine treatment, which significantly reduces our environmental impact. And because we use СО2 to produce urea, the Urea-6+ project helps decrease our carbon dioxide emissions by more than 350,000 tonnes per annum.

‘Demand is strong in the industrial segment as well. The Group boosted its output of industrial products by 17% to 1,066,000 tonnes. Apatite concentrate output increased 10% to 936,000 tonnes.

‘Prices continue to head upward, but major Russian fertiliser producers froze their key fertiliser prices for domestic farmers in July 2021 through the end of the autumn agricultural season. In October, the voluntary price freeze was extended through the end of 2021’.

Market Trends

In Q3 2021, global urea prices continued to climb. The FOB Baltic price approached USD 600 by the end of the quarter, reaching in October a post-2008 high of USD 700. This pricing trend was fuelled by Chinese government actions limiting urea exports, an energy crisis in Europe that led several producers to suspend operations, high grain prices, recovering demand for industrial urea, and active fertiliser purchases by India and Brazil.

In early October, the FOB Baltic price of AN hit USD 450, another post-2008 record. UAN prices set a historical record of USD 600. These upward price trends were supported by higher urea prices, which serve as a benchmark for other nitrogen fertilisers.

NPK prices were on the rise as well in Q3 2021, supported by a similar pricing trend for the basic product basket (urea, DAP, and potassium chloride). The NPK 16-16-16 premium over the basic product basket was 15%.

Average Indicative Prices, USD per t, FOB Baltic/Black Sea

Q3 2021Q2 2021Q3 2020Q3 2021 /

Q2 2021

Q3 2021 /

Q3 2020

NPK 16-16-1642535325320%68%


Sergey Dorofeev

Anastasiya Gromova

Tatiana Smirnova

Public Relations

Phone: +7 (495) 777-08-65 (ext. 5196)

Investor Contacts

Ilya Popov

Sergey Smirnov

Strategy and Investor Relations

Phone: +7 (495) 745-77-45 (ext. 5252)

Background Information

Acron Group is a leading vertically integrated mineral fertiliser producer in Russia and globally, with chemical production facilities in Veliky Novgorod (Acron) and Smolensk region (Dorogobuzh). The Group owns and operates a phosphate mine in Murmansk region (North-Western Phosphorous Company, NWPC) and is implementing a potash development project in Perm Krai (Verkhnekamsk Potash Company, VPC). It owns transportation and logistics infrastructure, including three Baltic seaport terminals and distribution networks in Russia and China. Acron subsidiary North Atlantic Potash Inc. (NAP) holds mining leases and an exploration permit for ten parcels of the potassium salt deposit at Prairie Evaporite, Saskatchewan, Canada. Acron also holds a minority stake (19.8%) in Polish Grupa Azoty S.A., one of the largest chemical producers in Europe.

In 2020, the Group sold 7.8 million tonnes of its main products to 74 countries, with Russia, Brazil, Europe, and the United States as key markets.

In 2020, the Group posted consolidated IFRS revenue of RUB 119,864 million (USD 1,661 million), with EBITDA of RUB 35,311 million (USD 489 million). Acron’s shares are traded on the Moscow Exchange, and its global depositary receipts are traded at the London Stock Exchange (ticker AKRN). Acron employs over 11,000 people.

For more information about Acron Group, please visit

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

HMNC Brain Health to Participate in the H.C. Wainwright 2nd Annual Psychedelics Conference1.12.2021 16:37:31 CET | Press release

MUNICH, Germany, Dec. 01, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the development of personalized therapies powered by predictive companion diagnostics, announced today that Chief Executive Officer, Benedikt von Braunmühl, Chief Clinical Development Officer, Dr. Hans Eriksson and Head of Operations, Dr. Maximilian Döbler will present at H.C. Wainwright’s 2nd Annual Psychedelics Conference on Monday, December 6th, 2021. In addition, Dr. Eriksson will participate in the ‘Future of Mental Healthcare’ panel at 2:30 p.m. Eastern Time. To attend, please register here. HMNC Brain Health’s virtual presentation will be available beginning Monday, December 6th at 7:00 a.m. Eastern Time and is accessible through the following webcast link: A webcast of the presentation will be available on the HMNC Brain Health Website for 90 days through the above webca

4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab1.12.2021 15:03:00 CET | Press release

AGC Biologics to produce Procizumab for early and late clinical phases at company’s Chiba and Copenhagen facilities Seattle, Dec. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with 4TEEN4 Pharmaceuticals GmbH (“4TEEN4”) to manufacture and commercialize Procizumab. The first-in-class monoclonal antibody Procizumab offers a new approach for the treatment of life-threatening diseases related to acute circulatory failure. Under the terms of the agreement, the companies will collaborate to transfer and optimize the manufacturing process for Procizumab. AGC Biologics will manufacture the clinical trial materials at its site in Chiba and transfer to its Copenhagen facility for all late phase activities including commercialization, to support early and late clinical phases and launch readiness of 4TEEN4’s monoclonal antibody. “We look forward to partnering with 4TEEN4

Kalmar’s proven straddle carrier technology to enhance operational capabilities at Kingston Freeport Terminal, Jamaica1.12.2021 15:00:00 CET | Press release

CARGOTEC CORPORATION, PRESS RELEASE, 1 DECEMBER 2021 AT 4 PM (EET) Kalmar, part of Cargotec, has signed a contract to supply the Kingston Freeport Terminal Limited (KFTL) with four diesel-electric straddle carriers for use at their terminal in Kingston, Jamaica. The order was booked in Cargotec's 2021 Q4 order intake with delivery scheduled to be completed during Q3 2022. KFTL is a strategic transhipment hub in the Caribbean, located at the exit of the Panama Canal and the crossroads of the North/South and East/West lines. The terminal was established in 2015, and it is part of Terminal Link, a joint venture between The CMA CGM Group, a world leader in shipping and logistics, and China Merchants Port (CMP). The four Kalmar Straddle Carriers are part of a progressive fleet renewal strategy geared to improve performance and reliability in the terminal's operation. KFTL’s equipment fleet already includes Kalmar straddle carriers, reachstackers, empty container handlers and terminal tracto

Sinch carries out second part of the directed new share issue of approximately 40 million shares announced on 30 September 20211.12.2021 14:50:00 CET | Press release

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Stockholm, Sweden – December 1, 2021 - Sinch AB (publ) (“Sinch” or the “Company”) carries out a directed new share issue through the issuance of 21 million new shares for a total consideration of approximately SEK 3,469 million. The new share issue constitutes the second part of the SEK 6.6 billion new share issue of in total 40,077,841 shares (the “Shares”) announced on 30 September 2021, the proceeds of which are used to partially fund the acquisition of Pathwire. The subscribers consisted of institutional investors, among others the Canada Pension Plan Investment Board (“CPP Investments”), Temasek, SeaTown Master Fund (“SeaTown”), and SB Northstar LP,

Sinch genomför den andra delen av den riktade nyemissionen om cirka 40 miljoner aktier som offentliggjordes den 30 september 20211.12.2021 14:50:00 CET | Pressemelding

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUERING ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, JAPAN, AUSTRALIEN, SYDAFRIKA, NYA ZEELAND, HONGKONG, SINGAPORE ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTIONEN ELLER PUBLICERING AV DETTA PRESSMEDDELANDE SKULLE KUNNA VARA OLAGLIG, KRÄVA YTTERLIGARE REGISTRERING ELLER ANDRA ÅTGÄRDER Stockholm, Sverige – 1 december 2021 – Sinch AB (publ) (“Sinch” eller “Bolaget”) genomför en riktad nyemission av 21 miljoner aktier mot en total teckningslikvid om cirka 3,469 miljarder kronor. Nyemissionen utgör den andra delen av den riktade nyemissionen om totalt cirka 6,6 miljarder kronor av 40 077 841 aktier (”Aktierna”) som offentliggjordes den 30 september 2021. Emissionslikviden från den riktade nyemissionen används för att delfinansiera förvärvet av Pathwire. Tecknarna bestod av institutionella investerare, däribland Canada Pension Plan Investment Board (”CPP Investments”), Temasek, SeaTown Master Fund (”Seatown

Voyager Closes Series A Funding, Marking $10M Raised1.12.2021 14:00:00 CET | Press release

Investment to fuel growth across the marine supply chain HOUSTON, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Voyager Portal, a software platform enabling companies to reduce cost, risk, and complexity in their marine supply chain, has today announced an $8.4 million Series A investment, led by Phaze Ventures. Other new investors include ScOp Venture Capital, Waybury Capital and Flexport. All existing investors followed in on this round. The new funding comes on the back of unprecedented growth since the company raised $1.5 million in seed money two years ago. Since then, revenue has increased 13x from Q3 2020 to Q3 2021 and was up 40% from Q2 2021. Additionally, Voyager surpassed the $1 billion-mark for freight managed on the platform. Voyager's customers include manufacturers, traders and shippers in the renewable energy, commodity trading, mining and petrochemicals industries. “Voyager Portal was created to significantly reduce cost, risk, and complexity when transporting bulk materials aroun

Agreements entered into regarding the sale of three Volvo facilities in Norway1.12.2021 13:40:00 CET | Press release

Bilia has today, as part of the agreement with Volvo Cars dated 1 October 2021, entered into agreements to sell three facilities in Norway, in the Oslo area, to the newly established company Volvo Car Stor-Oslo AS. The three facilities are located in Økern, Fornebu and Lillestrøm and conduct sales of new cars, used cars and service for Volvo cars. The sale is expected to take place on 1 July 2022. The transfer is subject to approval by the Norwegian competition authority. Gothenburg, December 1, 2021 Bilia AB (publ) For information please contact: Per Avander, Managing Director and CEO, +46 (0)10 497 70 00, Kristina Franzén, CFO, +46 (0)10 497 73 40, Facts about the Bilia Group Bilia is one of Europe’s largest car dealers with a leading position within service and sales of cars, transport vehicles and trucks. Bilia has about 160 facilities in Sweden, Norway, Germany, Luxembourg and Belgium. Bilia sells cars of the brand Volvo, BMW, Toyota,